# 8/22/25 - MyAgLife Episode 255: Interview with Nutrien's Dr. Karl Wyant on Addressing Plant Biostimulants in D.C.

Page: https://stenobird.com/podcast/the-myaglife-podcast-1018894/8-22-25-myaglife-episode-255-interview-with-nutrien-s-dr-karl-wyant-on-addressing-plant-biostimulants-in-d-c
Text version: https://stenobird.com/podcast/the-myaglife-podcast-1018894/8-22-25-myaglife-episode-255-interview-with-nutrien-s-dr-karl-wyant-on-addressing-plant-biostimulants-in-d-c.md
Podcast: [The MyAgLife Podcast](https://stenobird.com/podcast/the-myaglife-podcast-1018894)
Published: 2025-08-22T23:58:19+00:00
Episode link: https://share.transistor.fm/s/6e0ec5ae
Audio file: https://media.transistor.fm/6e0ec5ae/07cb5601.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-myaglife-podcast-1018894/episodes/8-22-25-myaglife-episode-255-interview-with-nutrien-s-dr-karl-wyant-on-addressing-plant-biostimulants-in-d-c
Duration seconds: 743

## Resource

Taylor Chalstrom sits down with Dr. Karl Wyant, director of agronomy at Nutrien, to discuss his recent visit to Washington D.C., where he advocated for the U.S. agriculture industry, seeking support for the Plant Biostimulant Act in the next Farm Bill.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-myaglife-podcast-1018894/episodes/8-22-25-myaglife-episode-255-interview-with-nutrien-s-dr-karl-wyant-on-addressing-plant-biostimulants-in-d-c/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-myaglife-podcast-1018894/8-22-25-myaglife-episode-255-interview-with-nutrien-s-dr-karl-wyant-on-addressing-plant-biostimulants-in-d-c.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.